(secondQuint)Safety and Efficacy Study of Ceftaroline in Elderly Subjects With Community-Acquired Bacterial Pneumonia.

 This is a multicenter study of ceftaroline fosamil in elderly subjects ( 65 years of age) with CABP.

 Adjunctive macrolide therapy is to be used at the Investigator's discretion.

 A switch to oral treatment may be allowed at the discretion of the Investigator.

 The total duration of therapy is 5 to 7 days; a minimum of 48 hours of study drug is required.

.

 Safety and Efficacy Study of Ceftaroline in Elderly Subjects With Community-Acquired Bacterial Pneumonia@highlight

The purpose of this study is to determine the safety and efficacy of ceftaroline fosamil in elderly subjects with community-acquired bacterial pneumonia (CABP) receiving antibiotic therapy in the hospital.

